Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
16.28
+0.32 (2.01%)
At close: Jul 8, 2025, 4:00 PM
15.60
-0.68 (-4.18%)
After-hours: Jul 8, 2025, 7:48 PM EDT
Tourmaline Bio Market Cap
Tourmaline Bio has a market cap or net worth of $418.21 million as of July 8, 2025. Its market cap has increased by 4.87% in one year.
Market Cap
418.21M
Enterprise Value
169.10M
1-Year Change
4.87%
Ranking
Category
Stock Price
$16.28
Market Cap Chart
Since October 20, 2023, Tourmaline Bio's market cap has increased from $221.67M to $418.21M, an increase of 88.66%. That is a compound annual growth rate of 44.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2025 | 409.99M | -21.16% |
| Dec 31, 2024 | 520.03M | -2.33% |
| Dec 29, 2023 | 532.42M | 140.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |